NASDAQ: WINT
Windtree Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their WINT stock forecasts and price targets.

Forecast return on equity

Is WINT forecast to generate an efficient return?

Company
N/A
Industry
29.26%
Market
56.76%

Forecast return on assets

Is WINT forecast to generate an efficient return on assets?

Company
N/A
Industry
10.9%

WINT earnings per share forecast

What is WINT's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.16

WINT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
WINT$0.59N/AN/A
PBM$4.54N/AN/A
ENTO$0.49N/AN/A
ALZN$3.24$180.00+5,455.56%Buy
PTIX$3.32N/AN/A

Windtree Therapeutics Stock Forecast FAQ

What is WINT's earnings growth forecast for 2025-2025?

(NASDAQ: WINT) Windtree Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 22.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 57.17%.

Windtree Therapeutics's earnings in 2025 is -$20,749,000.

In 2025, WINT is forecast to generate -$7,908,384 in earnings, with the lowest earnings forecast at -$7,908,384 and the highest earnings forecast at -$7,908,384.

If you're new to stock investing, here's how to buy Windtree Therapeutics stock.

What is WINT's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: WINT) forecast ROE is N/A, which is considered weak.

What is WINT's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: WINT) Windtree Therapeutics's current Earnings Per Share (EPS) is -$933.98. In 2025, WINT's EPS is forecast to hit -$2.16 (min: -$2.16, max: -$2.16).

What is WINT's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: WINT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 10.9%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.